Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Ciscom Corp. Strengthens Its Board of Directors with Addition of Two Experienced Industry Leaders (click to learn more) Silver North Options GDR Silver Project, Silvertip-Midway District, Yukon (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Sanofi 2 ADR Representing Ord Shs SNY

Healthcare
Sanofi SA is a France-based healthcare company based in France. The Company focuses on patient needs and engages in the research, development, manufacture, and marketing of therapeutic solutions. Its three operating segments are: Pharmaceuticals, Consumer Healthcare (CHC), and Vaccines. The Pharmaceuticals includes: Immunology, Multiple Sclerosis / Neurology, Oncology, Rare Diseases, Rare Blood... see more

Recent & Breaking News (NDAQ:SNY)

Attention Biotech Investors: Mark Your Calendar For These October PDUFA Dates

Benzinga.com  September 26, 2018

New Research Coverage Highlights Sanofi, Amdocs, GlaxoSmithKline plc, BT Group, Sociedad Quimica y Minera S.A, and ARMOUR Residential REIT — Consolidated Revenues, Company Growth, and Expectations for 2018

GlobeNewswire September 26, 2018

National Meningitis Association Urges Parents to Get Their Teens The 16 Vaccine to Help Protect Against Meningococcal Meningitis

PR Newswire September 17, 2018

FDA to review supplemental Biologics License Application for Praluent® (alirocumab) Injection as potential treatment to reduce major adverse cardiovascular events

GlobeNewswire September 12, 2018

Cablivi™ (caplacizumab) approved in Europe for adults with acquired thrombotic thrombocytopenic purpura (aTTP)

PR Newswire September 3, 2018

Q2 2018 Performance Positions Sanofi for New Growth Phase

PR Newswire July 31, 2018

Sanofi Ships First Flu Vaccines for 2018-2019 Season

PR Newswire July 30, 2018

New Insights Revealed in National Survey Show More Advances Are Needed for the Type 1 Diabetes Community

PR Newswire July 26, 2018

Sanofi denounces CADTH negative recommendation that could limit treatment options for Canadians with atopic dermatitis

Canada NewsWire July 10, 2018

Sanofi to further accelerate its scientific presence with the opening of a Global R&D Operations Hub in Chengdu, China

PR Newswire July 2, 2018

Sanofi: CHMP recommends approval of Cablivi(TM) (caplacizumab)

GlobeNewswire June 29, 2018

Sanofi : Sanofi and Advent finalize negotiations for the acquisition of Zentiva

GlobeNewswire June 28, 2018

Sanofi presents results from the first head-to-head study comparing Toujeo® to insulin degludec

PR Newswire June 25, 2018

NICE Recommends Sanofi's New Treatment Dupixent(R) ▼ (dupilumab) for Adults with Moderate to Severe Atopic Dermatitis in England[1]

PR Newswire Europe Non Regulatory June 22, 2018

Sanofi appoints Jean-Baptiste Chasseloup de Chatillon Executive Vice President, Chief Financial Officer

GlobeNewswire June 19, 2018

Sanofi : Sanofi completes its acquisition of Ablynx following the expiration of the Squeeze-out Procedure

GlobeNewswire June 19, 2018

Canadian employers underestimate the proportion of their workforce with a chronic condition and its impact

Canada NewsWire June 13, 2018

Sanofi : Sanofi successfully prices USD 2 billion bond issue

GlobeNewswire June 13, 2018

Sanofi Launches "Action 2018", a Worldwide Employee Stock Purchase Plan

GlobeNewswire June 11, 2018

New England Journal of Medicine Publishes Cemiplimab Trial Results in Advanced Cutaneous Squamous Cell Carcinoma[1]

PR Newswire Europe Non Regulatory June 5, 2018